Therapeutic agent for migraine

Details Therapeutic agent for migraine Therapeutic agent for migraine

A - Human Necessities

61

K

A61K 45/00 (2006.01) A61K 31/427 (2006.01) A61K 31/519 (2006.01) A61K 31/52 (2006.01) A61P 25/06 (2006.01)

Patent

CA 2731573

Provided are therapeutic and/or preventive agents for migraine which comprise, as an active ingredient, a compound having a selective adenosine A2A receptor antagonistic activity or a pharmaceutically acceptable salt thereof; therapeutic and/or preventive agents for migraine which comprise, as an active ingredient, a compound having a selective adenosine A2A receptor antagonistic activity, which has an affinity for the adenosine A2A receptor 10 times or higher than that for the adenosine A1 receptor, or a pharmaceutically acceptable salt thereof; and the like.

L'invention concerne un agent thérapeutique et/ou prophylactique antimigraineux, lequel agent renferme comme ingrédient actif un composé qui possède une activité antagoniste sélective pour un récepteur d'adénosine A2A, ou un sel pharmaceutiquement acceptable de ce dernier, ledit composé possédant une affinité pour le récepteur d'adénosine A2A au moins 10 fois supérieure à son affinité pour un récepteur d'adénosine A1; et autres.

Affiliated with

Also associated with

Rating

Therapeutic agent for migraine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic agent for migraine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for migraine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1972092